Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia
Yang, PC; Moreno, JD; Jeng, MT, Noskov, S; and Clancy, CE. Response to Wiliams et al, J Physiol, 1/1/2016Ranolazine for congenital and acquired late INa linked arrhythmias: in silico pharmacologic screening
Moreno, JD; Yang, PC; Bankston, JR; Grandi, E; Bers, DM; Kass, RS; Clancy, CE, Circ Res, 1/1/2013Pathophysiology of the cardiac late Na current and its potential as a drug target
Moreno, JD; Clancy, CE, Journal of Molecular and Cellular Cardiology, 1/1/2012A multiscale model to predict the effects of class I antiarrhythmic drugs on ventricular rhythms
Moreno, JD; Zhu, ZI; Yang, PC; Bankston, JR; Jeng, MT; Kang, C; Wang, L; Ripplinger, CM; Christini, DC; Kass, RS; Clancy, CE, Science Translational Medicine, 1/1/2011Cardiac Dynamics In-Silico: Pharmacological Targeting of Long QT3 Syndrome
Moreno, JD; Bankston, JR; Kass, RS; Clancy, CE, Biophys J, 1/1/2010Using computational modeling to predict arrhythmogenesis and antiarrhythmic therapy
Moreno, JD; Clancy, CE, Drug Discovery Today: Disease Models, 1/1/2010- Join now to see all